Enumeral Biomedical Holdings, Inc. 4

4 · Enumeral Biomedical Holdings, Inc. · Filed Dec 13, 2016

Insider Transaction Report

Form 4
Period: 2016-12-09
Sarney Kevin G
Vice President - Finance
Transactions
  • Other

    Common Stock Purchase Warrant

    2016-12-09$0.13/sh+35,000$4,37535,000 total
    Exercise: $0.50Exp: 2016-12-09Common Stock (35,000 underlying)
  • Purchase

    Common Stock Purchase Warrant

    2016-12-09$0.08/sh+8,750$7008,750 total
    Exercise: $2.00Exp: 2019-07-30Common Stock (8,750 underlying)
  • Exercise/Conversion

    Common Stock Purchase Warrant

    2016-12-09$0.13/sh35,000$4,3750 total
    Exercise: $0.50Exp: 2016-12-09Common Stock (35,000 underlying)
  • Exercise/Conversion

    Common Stock

    2016-12-09$0.13/sh+35,000$4,37535,000 total
Footnotes (3)
  • [F1]The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately.
  • [F2]The Reporting Person acquired the reported Warrants in a private sale transaction for cash consideration in the amount of $0.08 per warrant.
  • [F3]Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering.

Documents

1 file
  • 4
    s104941_form4.xmlPrimary

    4